Suppression of HBsAg Production in PLC/PRF/5 Human Hepatoma Cell Line by Interferons
- 14 November 1988
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 32 (11) , 1119-1126
- https://doi.org/10.1111/j.1348-0421.1988.tb01476.x
Abstract
Recombinant human interferon alpha 2a as well as natural human interferons α and β significantly suppressed the production of hepatitis B surface antigen by PLC/PRF/5 cells (which have been established from a human primary hepatocellular carcinoma and proven to carry the hepatitis B virus DNA) and inhibited proliferation of these cells in vitro. However, the production of α‐fetoprotein by PLC/PRF/5 cells was less significantly affected by any of the interferons. These results suggest that these interferons not only suppress cellular proliferation but also selectively inhibit the action of the HBV gene which is persistently present in these cells.This publication has 21 references indexed in Scilit:
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infectionAntimicrobial Agents and Chemotherapy, 1986
- Is Hepatitis B Virus A Retrovirus in Disguise?Science, 1982
- Evidence for Non-chromosomal Hepatitis B Virus Surface (HBsAg)- and Core Antigen (HBcAg)-specific DNA Sequences in a Hepatoma Cell LineJournal of General Virology, 1982
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomasHepatology, 1981
- Integration of hepatitis B virus sequences and their expression in a human hepatoma cellNature, 1980
- A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infectionInternational Journal of Cancer, 1980
- SERUM-α-FŒTOPROTEIN AND PRIMARY HEPATIC CANCERThe Lancet, 1968